MARK RUBIN, M.D.
Medical Oncology Physician · BONITA SPRINGS, FL
Individual Active NPI 1033192570
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,397 | 464,669 | $28,762,405 | $10,899,437 | $8,674,303 |
| 2023 | 1,323 | 470,975 | $26,559,059 | $9,569,518 | $7,614,036 |
| 2022 | 1,448 | 438,608 | $25,154,341 | $9,404,843 | $7,537,458 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 53,040 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 37,600 | $54 | $43 |
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 35,820 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 21,100 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 20,380 | $31 | $25 |
| J0185 | Injection, aprepitant, 1 mg | 19,630 | $2 | $1 |
| J1442 | Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 17,940 | $1 | $1 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 14,940 | $49 | $39 |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 12,530 | $8 | $6 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 10,818 | $45 | $36 |
| J9025 | Injection, azacitidine, 1 mg | 10,300 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 10,140 | $26 | $21 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | ME66879 | FL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Florida
- NPI 1023126232
- NPI 1760915169
- NPI 1376500769
- NPI 1215101902
- NPI 1861729170
- NPI 1811967243
- NPI 1699778894
- NPI 1184937518
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.